Spinocerebellar ataxia Clinical Trials in Montpellier
2 recruitingMontpellier, France
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene
Spinocerebellar Ataxia 27B (SCA27B)
Assistance Publique - Hôpitaux de Paris70 enrolled9 locationsNCT07185347
Recruiting
Phase 1Phase 2
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
Spinocerebellar Ataxia Type 3Spinocerebellar Ataxia Type 1Huntington Disease
Vico Therapeutics B. V.68 enrolled14 locationsNCT05822908